ストックスクリーナーアプリを入手
0.00
100.00%
-0.45
アフターアワーズ：
.26
0.26
+
前日終値:
$0.45
開ける：
$0
24時間の取引高:
0
Relative Volume:
0.00
時価総額：
$N/A
収益：
-
当期純損益:
$-5.16M
株価収益率:
0.00
EPS:
-3.4464
ネットキャッシュフロー:
$-4.14M
1週間 パフォーマンス:
-100.00%
1か月 パフォーマンス:
-100.00%
6か月 パフォーマンス:
-82.90%
1年 パフォーマンス:
-90.59%
1日の値動き範囲:
$0.00
$0.00
1週間の範囲:
$0.00
$0.00
52週間の値動き範囲:
$0.00
$0.75
Protagenic Therapeutics Inc Stock (PTIX) Company Profile
Compare PTIX vs VRTX, REGN, ARGX, RVMD, ALNY
| 株式 | 価格 | 時価総額 | 収益 | 当期純利益 | 現金流量 | EPS |
|---|---|---|---|---|---|---|
PTIX
Protagenic Therapeutics Inc
|
0.00 | 0 | 0 | -5.16M | -4.14M | -3.4464 |
VRTX
Vertex Pharmaceuticals Inc
|
480.50 | 123.26B | 12.34B | 4.34B | 3.71B | 16.87 |
REGN
Regeneron Pharmaceuticals Inc
|
672.15 | 70.94B | 14.92B | 4.42B | 3.79B | 41.04 |
ARGX
Argen X Se Adr
|
846.19 | 53.84B | 4.16B | 1.29B | 734.26M | 19.58 |
RVMD
Revolution Medicines Inc
|
180.39 | 39.58B | 742.00K | -1.37B | -1.07B | -7.0731 |
ALNY
Alnylam Pharmaceuticals Inc
|
272.67 | 35.71B | 4.29B | 577.22M | 641.34M | 4.2086 |
Protagenic Therapeutics Inc (PTIX) 最新ニュース
Enterprise value to EBIT forward of Protagenic Therapeutics, Inc. – OTC:PTIX - TradingView
Price to earnings forward of Protagenic Therapeutics, Inc. – OTC:PTIX - TradingView
Enterprise value to revenue forward of Protagenic Therapeutics, Inc. – MUN:MBP0 - TradingView
Price to book forward of Protagenic Therapeutics, Inc. – MUN:MBP0 - TradingView
Price to sales forward of Protagenic Therapeutics, Inc. – MUN:MBP0 - TradingView
Protagenic Therapeutics' Lead Candidate PT00114 Attenuated Chronic Stress Responses in a Well-Established Rodent Model - ACCESS Newswire
Protagenic Therapeutics announces publication of PT00114 preclinical data - TipRanks
Protagenic Therapeutics Delays Annual 10-K Filing - TipRanks
Protagenic Therapeutics (NASDAQ: PTIX) delays 10-K; expects filing within 15 days - Stock Titan
Protagenic Therapeutics (PTIX) Unveils Promising Data for PT0011 - GuruFocus
Protagenic Therapeutics, Inc. Actuals & Estimates (OTC:PTIX) - TradingView
Protagenic Therapeutics Inc (PTIX) Technical Analysis: Support, Resistance, Indicators & Moving Averages - TradingKey
Protagenic Therapeutics Inc (PTIX) Valuation: PE, PB & Fair Value Analysis - TradingKey
Protagenic Therapeutics Inc (PTIX) Financial Health: Profitability & Balance Sheet Analysis - TradingKey
Protagenic Therapeutics Inc (PTIX) Earnings Forecast: Future EPS & Revenue Growth Estimates - TradingKey
Protagenic Therapeutics Inc (PTIX) Institutional Confidence - TradingKey
Protagenic Therapeutics Inc (PTIX) Shareholder Structure: Major Shareholders & Institutional Holdings - TradingKey
Protagenic Therapeutics Inc (PTIX) Revenue Breakdown: Business Segments, Regional Revenue & Profit Contribution - TradingKey
Protagenic Therapeutics Inc (PTIX) Dividends & Stock Splits: Historical Payouts and Event Timeline - TradingKey
Protagenic Therapeutics Inc (PTIXW) Shareholder Structure: Major Shareholders & Institutional Holdings - TradingKey
Protagenic Therapeutics Inc (PTIXW) Dividends & Stock Splits: Historical Payouts and Event Timeline - TradingKey
Protagenic Therapeutics Inc - TradingKey
Protagenic Therapeutics Inc (PTIXW) Valuation: PE, PB & Fair Value Analysis - TradingKey
Protagenic Therapeutics Inc (PTIXW) Earnings Forecast: Future EPS & Revenue Growth Estimates - TradingKey
Protagenic Therapeutics Inc (PTIXW) Institutional Confidence - TradingKey
Protagenic Therapeutics Inc (PTIXW) Financial Health: Profitability & Balance Sheet Analysis - TradingKey
Protagenic Therapeutics Inc (PTIXW) Risk Assessment: Volatility, Financial Risk & Investment Risk - TradingKey
Protagenic Therapeutics Soars: Market Analysis Unfolded - timothysykes.com
PTIXW SEC FilingsProtagenic 10-K, 10-Q, 8-K Forms - Stock Titan
Protagenic Therapeutics (PTIX) Enhances Strategy for PT00114 Dev - GuruFocus
Protagenic Therapeutics Engages Floyd Regulatory Strategic Consulting as Regulatory Affairs Advisor - PharmiWeb.com
Protagenic announces two engagements to support advancement of PT00114 - TipRanks
Protagenic Therapeutics Engages Floyd Regulatory Strategic Consulting as Regulatory Affairs Advisor and Danforth Health as Strategic Operations Partner - ACCESS Newswire
Drug candidate PT00114 taps CNS regulatory veteran for 2026 Phase 2 - Stock Titan
TradingKey - TradingKey
Protagenic Theraputcs Wts (PTIXW) Stock Price and News - The Globe and Mail
Why Is Protagenic Therapeutics, Inc. (PTIX) Stock Up Today? - Meyka
Protagenic Therapeutics Appoints Industry Veteran Bill Nichols Jr. as President to Accelerate Advancement of First-in-Class TCAP Pathway Therapy PT00114 - Caledonian Record
Protagenic names Bill Nichols president, CFO to step down By Investing.com - Investing.com Nigeria
Protagenic Therapeutics Names Bill Nichols Jr. President to Advance Neuropeptide Pipeline Strategy - citybiz
Protagenic names Bill Nichols president, CFO to step down - Investing.com
Protagenic adds ex-bluebird executive as PT00114 moves toward Phase 2 - Stock Titan
PTIX SEC FilingsProtagenic Therapeutics Inc 10-K, 10-Q, 8-K Forms - Stock Titan
Guidance Update: What is the long term forecast for Protagenic Therapeutics Inc stock2026 Volume Leaders & Trade Opportunity Analysis - baoquankhu1.vn
Sentiment Review: Is Protagenic Therapeutics Inc Equity Warrant showing insider buyingWeekly Gains Summary & Weekly Return Optimization Plans - baoquankhu1.vn
Rate Hike: Is Protagenic Therapeutics Inc being accumulated by smart money2026 Winners & Losers & Safe Entry Zone Tips - baoquankhu1.vn
PTIX | PROTAGENIC THERAPEUTICS Insider Trading - Quiver Quantitative
Analyst Upgrade: How much upside does Protagenic Therapeutics Inc have2026 Technical Overview & Stepwise Entry and Exit Trade Signals - baoquankhu1.vn
Investor Mood: What is the long term forecast for Protagenic Therapeutics Inc stockDip Buying & Detailed Earnings Play Alerts - baoquankhu1.vn
PTIX|Protagenic Therapeutics Inc|Price:0.740| - TradingKey
Fed Meeting: Will Protagenic Therapeutics Inc Equity Warrant outperform during market rallies2026 Rallies & Low Drawdown Trading Techniques - baoquankhu1.vn
Protagenic Therapeutics Inc (PTIX) 財務データ
収益
当期純利益
現金流量
EPS
0.74%
3.77%
大文字化:
|
ボリューム (24 時間):